Evidence map›Paper›PMID 30011373›Full record

ArticleAmerican journal of respiratory cell and molecular biology2018

Ager-CreER

Mei-I Chung, Brigid L M Hogan

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Breathing new life into the study of COPD with genes identified from genome-wide association studies.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  9. Article
  10. Defining signals that promote human alveolar type I differentiation.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Lung Regeneration: Cells, Models, and Mechanisms.Cold Spring Harbor perspectives in biology · 2022
    Review
  17. Article
  18. Case report:Frontiers in immunology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mei-I ChungDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina.
Brigid L M HoganDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina.
Duke Medical Center · USDuke University Hospital · US

Funding

Progenitor Cells in Lung Development and RepairR37HL071303 · NHLBI · DUKE UNIVERSITY · PI HOGAN, BRIGID L.M. · 2008 to 2017
$4.1M
NHLBI NIH HHS R37 HL071303
6 · The paper itself

Abstract

The alveolar region of the lung is composed of two major epithelial cell types: cuboidal alveolar type 2 cells (AT2 cells), which produce surfactant proteins, and large, thin, alveolar type 1 cells (AT1 cells), specialized for efficient gas exchange. AT1 cells cover more than 95% of the alveolar surface and constitute a major barrier to the entry of pathogenic agents. Relatively few genetic tools are available for studying the development of AT1 cells, the function of genes expressed in them, and the effect of specifically killing them in vivo in the adult lung. One distinguishing feature of AT1 cells is the high level of expression of the gene Ager, encoding the advanced glycation endproduct-specific receptor, a member of the immunoglobulin superfamily of cell surface receptors. In this paper, we report the generation of a novel Ager-CreER

Indexed as

HomeostasisOrganogenesisAnimalsCell DifferentiationCells, CulturedFemaleIntegrasesMiceMice, Inbred C57BLPulmonary AlveoliReceptor for Advanced Glycation End ProductsReceptors, EstrogenAger protein, mouseCre recombinaseIntegrasesReceptor for Advanced Glycation End ProductsReceptors, EstrogenAgerCre recombinaselungtype 1 alveolar epithelial cellstype 2 alveolar stem cells

Identifiers

PMID30011373
PMCPMC6293079
OpenAlexW2884134188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.